These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3098121)

  • 1. Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine in African trypanosomes and Pneumocystis carinii as a basis of chemotherapy: biochemical and clinical aspects.
    McCann PP; Bacchi CJ; Clarkson AB; Bey P; Sjoerdsma A; Schecter PJ; Walzer PD; Barlow JL
    Am J Trop Med Hyg; 1986 Nov; 35(6):1153-6. PubMed ID: 3098121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies on difluoromethylornithine in African trypanosomes.
    McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
    Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyamine metabolism: a potential therapeutic target in trypanosomes.
    Bacchi CJ; Nathan HC; Hutner SH; McCann PP; Sjoerdsma A
    Science; 1980 Oct; 210(4467):332-4. PubMed ID: 6775372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of lethal protozoal infections with the ornithine decarboxylase inhibitor, alpha-difluoromethylornithine.
    Sjoerdsma A; Golden JA; Schechter PJ; Barlow JL; Santi DV
    Trans Assoc Am Physicians; 1984; 97():70-9. PubMed ID: 6442954
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of sleeping disease caused by trypanosoma brucei gambiense with alpha-difluoromethylornithine (DFMO) in a rural hospital in Zaire].
    De Groof D; Bruneel H; Musumari TS; Ruppol JF
    Med Trop (Mars); 1992; 52(4):369-75. PubMed ID: 1494306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis carinii pneumonia treated with alpha-difluoromethylornithine. A prospective study among patients with the acquired immunodeficiency syndrome.
    Golden JA; Sjoerdsma A; Santi DV
    West J Med; 1984 Nov; 141(5):613-23. PubMed ID: 6440364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness.
    Milord F; Pépin J; Loko L; Ethier L; Mpia B
    Lancet; 1992 Sep; 340(8820):652-5. PubMed ID: 1355219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of difluoromethylornithine in congenital trypanosomiasis due to Trypanosoma brucei-gambiense].
    Pepin J; Guern C; Milord F; Ethier L; Bokelo M; Schechter PJ
    Med Trop (Mars); 1989; 49(1):83-5. PubMed ID: 2498607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DFMO: an alternative therapeutic agent for human African trypanosomiasis].
    Breton JC; Bouteille B; Sonan T
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):571-7. PubMed ID: 3143490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of polyamines on two strains of Trypanosoma brucei in infected rats and in vitro culture.
    Nishimura K; Yanase T; Araki N; Ohnishi Y; Kozaki S; Shima K; Asakura M; Samosomsuk W; Yamasaki S
    J Parasitol; 2006 Apr; 92(2):211-7. PubMed ID: 16729674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of human late stage gambiense trypanosomiasis with alpha-difluoromethylornithine (eflornithine): efficacy and tolerance in 14 cases in Côte d'Ivoire.
    Doua F; Boa FY; Schechter PJ; Miézan TW; Diai D; Sanon SR; De Raadt P; Haegele KD; Sjoerdsma A; Konian K
    Am J Trop Med Hyg; 1987 Nov; 37(3):525-33. PubMed ID: 3120607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eflornithine. A new drug in the treatment of sleeping sickness.
    Van Bogaert I; Haemers A
    Pharm Weekbl Sci; 1989 Jun; 11(3):69-75. PubMed ID: 2505225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness.
    Pepin J; Milord F; Guern C; Schechter PJ
    Lancet; 1987 Dec; 2(8573):1431-3. PubMed ID: 2891995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new molecule in antiparasitic therapy: alpha-difluoromethylornithine].
    Furet Y; Duong TH; Combescot C; Breteau M
    Pathol Biol (Paris); 1987 Apr; 35(4):398-404. PubMed ID: 3108836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of human trypanosomiasis caused by Trypanosoma brucei gambiense using alpha-difluoromethylornithine. Results in 7 patients].
    Taelman H; Marcelis L; Sonnet J; Kazyumba G; Van den Enden E; Wery M; Schechter PJ
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):578-88. PubMed ID: 3143491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.
    Zweygarth E; Kaminsky R
    Acta Trop; 1991 Jan; 48(3):223-32. PubMed ID: 1671624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamine metabolism in Pneumocystis carinii.
    Lipschik GY; Masur H; Kovacs JA
    J Infect Dis; 1991 May; 163(5):1121-7. PubMed ID: 2019760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense.
    Bacchi CJ; Nathan HC; Livingston T; Valladares G; Saric M; Sayer PD; Njogu AR; Clarkson AB
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1183-8. PubMed ID: 2118325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models.
    Bacchi CJ; Nathan HC; Clarkson AB; Bienen EJ; Bitonti AJ; McCann PP; Sjoerdsma A
    Am J Trop Med Hyg; 1987 Jan; 36(1):46-52. PubMed ID: 3101528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantiospecific reassessment of the pharmacokinetics and pharmacodynamics of oral eflornithine against late-stage Trypanosoma brucei gambiense sleeping sickness.
    Jansson-Löfmark R; Na-Bangchang K; Björkman S; Doua F; Ashton M
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1299-307. PubMed ID: 25512417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.